The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...

The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

CEO Dexter Tjoa shares insights on the company’s journey, from early barcoding breakthroughs to embracing advanced ...

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.

High-level results from an ongoing clinical trial make Astrazeneca’s combination treatment the first to show benefit in a subtype of prostate cancer. AstraZeneca has reported positive results from the ...

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and sponsors. In this Q&A, Steve shares how ...

Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults. Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its ...

By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...